Innovative Heart Therapy VisCardia is developing a novel implantable device for chronic heart failure therapy that has recently received a prestigious innovation award at EuroPCR 2025, indicating strong recognition in the medical community and potential for widespread adoption.
Strategic Clinical Partnerships The company's collaboration with Clinical Accelerator for clinical trials in Ukraine demonstrates proactive efforts to validate and expand its device’s geographic reach, presenting opportunities to partner with hospitals and research institutions worldwide.
Funding and Growth Potential With $13 million in funding and a focus on innovative cardiac therapies, VisCardia is positioned to attract further investment and strategic partnerships to accelerate product development and commercialization.
Target High-Impact Market Focusing on the 10 million patients affected by heart failure in the US and Europe, the company's targeted market provides significant growth potential for medical device sales and hospital adoption.
Technology and Industry Position Utilizing a tech stack including Microsoft 365 and web development tools, VisCardia emphasizes innovative product development and digital engagement, which can be leveraged to enhance sales and training efforts with healthcare providers.
$10M$25M
$1M$10M
$50M$100M
$100M$250M
$1M$10M
$10M$25MViscardia uses 8 technology products and services including Microsoft 365, Twemoji, jQuery, and more. Explore Viscardia's tech stack below.
| Viscardia Email Formats | Percentage |
| LastF@viscardia.com | 33% |
| FirstLast@viscardia.com | 17% |
| LastF@viscardia.com | 33% |
| FirstLast@viscardia.com | 17% |
Medical Equipment ManufacturingOregon, United States2-10 Employees
VisCardia Inc is a privately held medical device company in Portland Oregon developing a novel chronic heart failure therapy. The VisOne implantable system delivers Synchronized Diaphragmatic Stimulation (SDS) which generates transient intrathoracic pulses gaited to cardiac activity and augments cardiac hemodynamics.
Company Overview
Media & News
Funding & FinancialsViscardia has raised a total of $13M of funding over 2 rounds. Their latest funding round was raised on Feb 01, 2017 in the amount of $13M.
Viscardia's revenue is estimated to be in the range of $1M
Funding & FinancialsViscardia has raised a total of $13M of funding over 2 rounds. Their latest funding round was raised on Feb 01, 2017 in the amount of $13M.
Viscardia's revenue is estimated to be in the range of $1M
1-888-653-2347 
support@leadiq.com